Preclinical Evaluation of the Efficacy, Pharmacokinetics and Immunogenicity of JS-001, a Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody
Acta Pharmacologica Sinica - United Kingdom
doi 10.1038/aps.2016.161
Full Text
Open PDFAbstract
Available in full text
Date
March 20, 2017
Authors
Publisher
Springer Science and Business Media LLC